MHRA drops 2010 fee increase to 1%
The Medicines and Healthcare products Regulatory Agency (MHRA) says it plans to increase its licensing fees just 1% from next April. Last year, the Agency had been projecting a fee increase of 3%-4%.
Read MoreAuthor: Lynne Taylor
Govt to reveal NHS spending on management consultants
Starting next summer, the Department of Health will publish details of how much NHS organisations spend per year on management consultants, the government announced late last week.
Read MoreLong-term use causing antidepressant prescribing to soar: study
During 1993-2004, the number of UK patients newly-diagnosed with depression declined by nearly 25%, but numbers of prescriptions written for antidepressants nearly doubled in the same period, says a new study.
Read MoreVaccines production and use now at record levels, says WHO
Vaccine development worldwide is booming, more vaccines are now available against deadly diseases than ever before and levels of infant immunisation have reached record levels, at 106 million last year, says a new report from world health experts.
Read MoreUS pharma lobbying bill soars
US drugmakers and health insurers spent 30% more on political lobbying in the first nine months of 2009 than they did in the same period last year, new figures show.
Read More- FDA approves new high dose Spinraza regimen for SMA
- Viridian reports positive results from elegrobart phase 3 trial
- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
- Kygevvi approved in Europe as first treatment for TK2d
- Tozorakimab shows significant benefit in two major COPD trials
